WASHINGTON (NewsNation Now) — The U.S. Food and Drug Administration authorized Johnson and Johnson’s single-dose COVID-19 vaccine for emergency use Saturday, making it the third vaccine available in ...

Bayer has filed patent infringement lawsuits against COVID-19 vaccine makers Pfizer, BioNTech, Moderna, and Johnson & Johnson. The company claims these firms misused mRNA technology pioneered by ...

WASHINGTON - On Tuesday, U.S. officials recommended a "pause" on the use of the Johnson & Johnson COVID-19 vaccine in order to investigate U.S. reports of a rare type of blood clot following ...

SAN FRANCISCO (KGO) -- A one-dose COVID-19 vaccine has been given the green light to resume. The CDC and FDA said Saturday Johnson and Johnson vaccinations can resume immediately, after being halted ...

A top doctor is pushing back against a panel of experts' decision to delay voting on a recommendation to give to the Centers for Disease Control and Prevention regarding the Johnson & Johnson COVID-19 ...

Johnson & Johnson said Wednesday that new data from early trials of a booster shot of its COVID-19 vaccine provides a "rapid and robust increase in spike-binding antibodies" that fight off the virus.

Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.

According to Bayer, vaccine manufacturers including Pfizer, BioNTech, and Moderna copied technology pioneered by Monsanto in ...